Asclepia MedChem Solutions was founded in January 2009. The management has in depth experience in drug discovery. Before joining Asclepia MedChem Solutions, the founder has built her career in companies/biotechs such as UCB (Taminco), Devgen and Oncodesign Precision Medicine where she developed both scientific and managerial experience.
Major milestones have been achieved over the years leading discovery programs on a consultancy basis in collaboration with Ipsen, UCB, Sanofi, BMS, Servier, iTeos within disease areas such as cardiovascular, neurology, oncology, inflammation, auto-immune diseases, ophthalmology etc. These have resulted in four New Molecular Entities in the field of inflammation, neuroscience, and oncology.